Skip to Content

Percheron Therapeutics Ltd ATHJF

Morningstar Rating
$0.01 −0.04 (80.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ATHJF is trading at a 40% discount.
Price
$0.01
Fair Value
$9.96
Uncertainty
Extreme
1-Star Price
$7.13
5-Star Price
$9.70
Economic Moat
Wzkk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ATHJF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.05
Day Range
$0.010.01
52-Week Range
$0.010.07
Bid/Ask
$0.01 / $0.10
Market Cap
$9.02 Mil
Volume/Avg
24,000 / 12,167

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
8

Valuation

Metric
ATHJF
Price/Earnings (Normalized)
Price/Book Value
0.80
Price/Sales
Price/Cash Flow
Price/Earnings
ATHJF

Financial Strength

Metric
ATHJF
Quick Ratio
5.62
Current Ratio
5.66
Interest Coverage
−1,842.00
Quick Ratio
ATHJF

Profitability

Metric
ATHJF
Return on Assets (Normalized)
−63.04%
Return on Equity (Normalized)
−75.63%
Return on Invested Capital (Normalized)
−79.36%
Return on Assets
ATHJF
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRXdxztcrbpcMdkgfxm$70.5 Bil
ZTS
Zoetis Inc Class AQwhbvjxvvQjpq$69.4 Bil
HLN
Haleon PLC ADRRhslpsysLbkr$36.6 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRNnjrtznlsVqtz$14.9 Bil
VTRS
Viatris IncVjqtdqgmCct$13.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRGmjrqgrSksp$12.0 Bil
CTLT
Catalent IncMxwjxkdJnlkkm$10.1 Bil
PRGO
Perrigo Co PLCBnslgkznqQlq$4.1 Bil
CURLF
Curaleaf Holdings IncMcdzmrgbRcml$3.7 Bil
PBH
Prestige Consumer Healthcare IncXhsybrqdCcygv$3.4 Bil

Sponsor Center